Sandu Pharmaceuticals Limited (BOM:524703)

Market Cap	381.61M
Revenue (ttm)	667.62M
Net Income (ttm)	16.32M
Shares Out	9.66M
EPS (ttm)	1.68
PE Ratio	23.52
Forward PE	n/a
Dividend	0.80 (2.03%)
Ex-Dividend Date	Sep 18, 2025

Volume	2,052
Average Volume	2,148
Open	40.00
Previous Close	40.20
Day's Range	39.03 - 40.00
52-Week Range	37.00 - 62.80
Beta	0.08
RSI	40.07
Earnings Date	Nov 12, 2025

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasav...

• Industry: Pharmaceutical Preparations
• Founded: 1899
• Employees: 303
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524703

Financial Performance

In 2024, Sandu Pharmaceuticals's revenue was 671.92 million, a decrease of -0.13% compared to the previous year's 672.81 million. Earnings were 15.52 million, an increase of 6.19%.